CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 33 target
Drug / intervention
bupivacaine 0.5%drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01244932
NCT01244932Phase 2Completed
CompareCT.gov

Determination of the Minimum Effective Volume of Local Anesthetic Using Ultrasound Guidance for Interscalene Brachial Plexus Block

Federal University of São Paulo·interventional·Posted Nov 22, 2010·Updated May 10, 2012

In Brief

A Phase 2 clinical trial evaluating bupivacaine 0.5% for Anesthesia. Completed, enrolled 33 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the minimum effective volume of local anesthetic for interscalene brachial plexus block using ultrasound guidance and nerve stimulator guidance.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnesthesia
CountriesBrazil
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 22, 2010
Enrollment StartSep 1, 2009
Primary CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.6 years ago

Interventions

bupivacaine 0.5%drug

Patients will be given bupivacaine 0.5% in different doses (up-down study).